Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2003-04-30
2009-02-10
Zeman, Robert A. (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S133100, C424S135100, C424S141100, C530S388100, C530S388200, C530S388300
Reexamination Certificate
active
07488477
ABSTRACT:
The present invention relates to the identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies retaining RSV-binding ability, and pharmaceutical compositions including such antibodies. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. Finally, the invention provides for diagnostic and therapeutic methods employing the antibodies and nucleic acids of the invention.
REFERENCES:
patent: 4800078 (1989-01-01), Prince et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: WO 92/04381 (1992-03-01), None
patent: WO 93/20210 (1993-10-01), None
patent: WO 94/06448 (1994-03-01), None
patent: WO 94/17105 (1994-08-01), None
patent: WO 95/03832 (1995-02-01), None
patent: WO 95/04081 (1995-02-01), None
Greenspan et al. (Nature Biotechnology 17: 936-937, 1999).
Barbas et al., “Assembly of Combinatorial Antibody Libraries on Phage Surfaces: The Gene III Site”, Proc. Natl. Acad. Sci. (USA), 1991, 88:7978-7982.
Barbas et al., “Human Monoclonal Fab Fragments Derived From a Combinatorial Library Bind to Respiratory Syncytial Virus F. Glycoprotein and Neutralize Infectivity”, Proc. Natl. Acad. Sci. (USA), 1992, 89:10164-10168.
Better et al., “Escherichia coliSecretion of an Active Chimeric Antibody Fragment” Science, 1988, 240:1041-1043.
Burton et al., “Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody”, Science, 1994, 266:1024-1027.
Burton et al., “A Large Array of Human Monoclonal Antibodies to Type 1 Human Immunodeficiency Virus From Combinatorial Libraries of Asymptomatic Seropositive Individuals”, Proc. Natl. Acad. Sci. (USA), 1991, 88:10134-10137.
Clackson et al., “Making Antibody Fragments Using Phage Display Libraries”, Nature, 1991, 352:624-628.
Clark, William R., “The Experimental Foundations of Modern Immunology, 3rd Ed.”, John Wiley & Sons, 1986.
Coates et al., “An Antigenic Analysis of Respiratory Syncytial Virus Isolates By a Plaque Reduction Neutralization Test”, American Journal of Epidemiology, 1966, 83(2):299-313.
Duan et al., “Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication by an Intracellular Anti-Rev Single-chain Antibody”, Proc. Natl. Acad. Sci. (USA), 1994, 91:5075-5079.
Gold et al., “Translational Initiation in Prokaryotes”, Rev. Microbiol., 1981, 35:365-403.
Guarente et al., “Improved Methods for Maximizing Expression of a Cloned Gene: a Bacterium That Synthesizes Rabbit β-Globin”, Cell, 1980 20:543-553.
Guarente et al., “A Technique for Expressing Eukaryotic Genes in Bacteria”, Science, 1980, 209:1428-1430.
Hemming et al., “Intravenous Immunoglobulin Treatment of Respiratory Syncytial Virus Infections in Infants and Young Children”, Antimicrob. Agnts. Chemotherap., 1987, 31(12): 1882-1886.
Hemming et al., “Studies of Passive Immunotherapy for Infections of Respiratory Syncytial Virus in the Respiratory Tract of a Primate Model”, J. Inf. Dis., 1985, 152:1083-1087.
Herlyn et al., “Anti-Idiotypic Antibodies Bear the Internal Image of a Human Tumor Antigen”, Science, 1986, 232:100-102.
Huse et al., “Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda”, Science, 1989, 246:1275-1281.
Jones et al., “Replacing the Complementarity-determining Regions in a Human Antibody With Those From a Mouse”, Nature 1986, 321:522-525.
Kang et al., “Combinatorial Immunoglobulin Libraries in Phage λ”, Methods: A Companion to Methods in Enzymology, 1991, 2(a):111-118.
Köhler et al., “Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity”, Nature, 1997, 256:495-497.
Lai et al., “Conserved Organization of the Human and Murine T-Cell Receptor β-gene Families”, Division of Biology 147-75, Letters to Nature, 1988, 331:543-546.
Marasco et al., “Design, Intracellular Expression, and Activity of a Human Anti-human Immunodeficiency Virus Type 1 gp120 Single-chain Antibody”, Proc. Natl. Acad. Sci. (USA), 1993, 90:7889-7893.
Marks et al., “By-passing Immunization Human Antibodies from V-gene Libraries Displayed on Phage”, J. Mol. Biol., 1991, 222:581-597.
McIntosh et al., “Respiratory Syncytial Virus”, Virology, 2nd ed., 1990, 38:1045-1072.
Mullinax et al., “Identification of Human Antibody Fragment Clones Specific for Tetanus Toxoid in a Bacteriophage λ Immunoexpression Library”, Proc. Acad. Sci. (USA), 1990, 87:8095-8099.
Murphy et al., “Enhanced Pulmonary Histophathology is Observed in Cotton Rats Immunized With Formalin-inactivated Respiratory Syncytal Virus (RSV) or Purified F Glycoprotein and Challenged With RSV 3-6 Months After Immunization”, Vaccine, 1990, 8:497-502.
Ogilvie et al., “Maternal Antibody and Respiratory Syncytial Virus Infection in Infancy”, J. Med. Virol., 1981, 7:263-271.
Oliver, Donald B., “Periplasm and Protein Secretion”,Escherichia coliandSalmonella typhimuriumCellular and Molecular Biology, American Society for Microbiology, 1987, 1:56-69.
Prince et al., “The Pathogenesis of Respiratory Syncytial Virus Infection in Cotton Rats”, Am. Assoc. of Path., 1978, 93:771-792.
Prince et al., “Quantitative Aspects of Passive Immunity to Respiratory Syncytial Virus Infection in Infant Cotton Rats”, J. Virol., 1985, 55:517-520.
Prince et al., “Effectiveness of Topically Administered Neutralizing Antibodies in Experimental Immunotherapy of Respiratory Syncytial Virus Infection in Cotton Rats”, J. Virol., 1987, 61(6):1851-1854.
Prince et al., “Immunoprophylaxis and Immunotherapy of Respiratory Syncytial Virus Infection in the Cotton Rat”, Virus Research, 1985, 3:193-206.
Roberts et al., “A General Method for Maximizing the Expression of a Cloned Gene”, Proc. Natl. Acad. Sci. (USA), 1979, 76(2):760-764.
Roberts et al., “Synthesis of Simian Virus 40 t Antigen inEscherichia coli”, Proc. Natl. Acad. Sci. (USA), 1979, 76(11):5596-5600.
Roberts et al., “Directed Evolution of a Protein: Selection of Potent Neutrophil Elastase Inhibitors Displayed on M13 Fusion Phage” Proc. Natl. Acad. Sci (USA), 1992, 89:2429-2433.
Roitt, Ivan M., “Essential Immunology”, 7th Ed. (Blackwell Scientific Publications), 1991.
Sambrook et al., “Molecular Cloning: A Laboratory Manual, 2nd Ed.”, 11-38, 1989.
Sastry et al., “Cloning of the Immunological Repertoire inEscherichia colifor Generation of Monoclonal Catalytic Antibodies: Construction of a Heavy Chain Variable Region-specific cDNA Library”, Proc. Natl. Acad. Sci. (USA), 1989, 86:5728-5732.
Sciarra et al., “Aerosols”, Remington's Pharmaceutical Sciences, 1990, 92:1694-1712.
Shine et al., “Determined of Cistron Specificity in Bacterial Ribosomes”, Nature, 1975, 254:34-38.
Smith et al., “Filamentous Fusion Phage: Novel Expression Vectors that Display Cloned Antigens on the Virion Surface”, Science, 1985, 228:1315-1317.
Taniguchi et al., “Site-directed Mutations in the Initiator Region of the Bacteriophage Qβ Coat Cistron and Their Effect on Ribosome Binding”, J. Mol. Biol., 1978, 118:533-565.
Taylor et al., “Monoclonal Antibodies Protect Against Respiratory Syncytial Virus Infection in Mice”, Immunology, 1984, 52:137-142.
Tempest et al., “Reshaping a Human Monoclonal Antibody to Inhibit Human Respiratory Syncytial Virus Infection In Vivo”, Bio/Technology, 1991, 9:266-271.
Verhoeyen et al., “Reshaping Human Antibodies: Grafting an Antilysozy
Chanock Robert M.
Crowe, Jr. James E.
Gilmour Page S.
Murphy Brian R.
Pilkington Glenn R.
Dickstein & Shapiro LLP
Intracel Resources LLC
Zeman Robert A.
LandOfFree
Neutralizing monoclonal antibodies to respiratory syncytial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neutralizing monoclonal antibodies to respiratory syncytial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neutralizing monoclonal antibodies to respiratory syncytial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4128113